HepcdacDaklinzaDaclatasvir 60mg, is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.

Limitations of Use: Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.

Hepcdac’s brand name is Daklinza by Bristol-Myers Squibb. Hepcdac is a generic oncologic prescription medicine from Cipla, which is one of the biggest pharmaceutical company in India.


There are no reviews yet.

Be the first to review “Buy Hepcdac (Daklinza) Daclatasvir 60mg Online”

Your email address will not be published. Required fields are marked *